Fundraising Fox

Medzown

Founded 2022 · 39 employees on LinkedIn · 2 known investors

Precision medicine management aligning payer and pharmaceutical incentives around patients with complex oncology and rare diseases.

Investors · 2

GOVO Venture PartnersWinter Park
Service Provider CapitalreportedVail

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Immunome6 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.

Companies competing with Medzown for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

How Sun Life’s Capital Note Reset and Health Push Will Impact Sun Life Financial (TSX:SLF) Investors - Simply Wall St Newssimplywall.st · Jul 2026GOVO Venture Partners Invests in Medzown — Govo Venture Partnersgovovp.com · Feb 2024

Frequently asked questions

What does Medzown do?
Precision medicine management aligning payer and pharmaceutical incentives around patients with complex oncology and rare diseases.
Who are Medzown's investors?
Medzown's investors include GOVO Venture Partners, Service Provider Capital.